[cnbc 3000108735]
Dr. Leonard Schleifer, Regeneron Pharmaceuticals president/CEO, discusses the strategies behind his company’s products, and why people using the same drug are switching to his company versus another.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Video © and provided by CNBC.
With a reach of over 400 million CNBC is ground zero for traders and investors monitoring the financial world.
Be the first to comment